JamesHermanMD
Oncology • Pittsburgh, PAHematologic Oncology, Thoracic Cancer
Professor of Medicine, University of Pittsburgh Cancer Institute
Dr. Herman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Avenue
Pittsburgh, PA 15232Phone+1 412-623-7769
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1992 - 1996
Duke University HospitalResidency, Internal Medicine, 1989 - 1992- Johns Hopkins University School of MedicineClass of 1989
Hope CollegeBA, Chemistry, Summa Cum Laude, 1980 - 1984
Certifications & Licensure
MD State Medical License 1992 - 2026
PA State Medical License 2016 - 2024
NC State Medical License 1991 - 1998- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Neighborhood-level deprivation and survival in lung cancer.Kathleen Kennedy, Ignacio Jusue-Torres, Ian D Buller, Emily Rossi, Apurva Mallisetty
BMC Cancer. 2024-08-06 - 3 citationsEpigenetic silencing of BEND4, a novel DNA damage repair gene, is a synthetic lethal marker for ATM inhibitor in pancreatic cancer.Yuanxin Yao, Honghui Lv, Meiying Zhang, Yuan Li, James G Herman
Frontiers of Medicine. 2024-08-01 - 2 citationsMethylation ofis a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer.Fengna Liu, Aiai Gao, Meiying Zhang, Yazhuo Li, Fan Zhang
Journal of Translational Internal Medicine. 2024-06-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
